Symptom Assessment

The minimum incubation period for Ebola virus may not actually be 2 days, researchers wrote in The Lancet Infectious Diseases.

Assessing benefits of aficamten (Cytokinetics) on obstructive hypertrophic cardiomyopathy (HCM) symptom burden and QOL at 6 months.

NATIONAL HARBOR, Md. — Aficamten was associated with sustained improvement in patient-reported symptom burden and quality of life at 6 months when used to treat obstructive hypertrophic cardiomyopathy, a speaker reported.

Results of a recently released poll revealed that roughly 60% of patients with Parkinson’s disease do not believe their symptoms are manageable and cannot be improved beyond their current state.

High symptom burden patterns in patients with COPD are consistent over time and individual symptom experiences should be the main focus in treatment among these patients, researchers concluded in Respiratory Medicine Journal.

Longer time since trauma was associated with larger symptom reductions among patients with PTSD, according to study results published in Journal of Clinical Psychiatry.

Understanding symptom clusters could help practitioners manage the symptoms of chronic kidney disease, researchers said in a poster presented at the American Nephrology Nurses Association National Symposium.